These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 28397579)

  • 21. Tremor in multiple sclerosis is associated with cerebello-thalamic pathology.
    Boonstra F; Florescu G; Evans A; Steward C; Mitchell P; Desmond P; Moffat B; Butzkueven H; Kolbe S; van der Walt A
    J Neural Transm (Vienna); 2017 Dec; 124(12):1509-1514. PubMed ID: 29098451
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical commentary on "Paroxysmal kinesigenic dyskinesia-like phenotype in multiple sclerosis" and "Secondary paroxysmal dyskinesia in multiple sclerosis: Clinical-radiological features and treatment. Case report of seven patients".
    Pareés I
    Mult Scler; 2017 Nov; 23(13):1797-1798. PubMed ID: 28397577
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A rare paroxysmal movement disorder: mixed type of paroxysmal dyskinesia.
    Sen A; Atakli D; Guresci B; Arpaci B
    Ideggyogy Sz; 2014 Nov; 67(11-12):426-9. PubMed ID: 25720246
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Beneficial effects of acetazolamide on paroxysmal attacks of girdle sensation in multiple sclerosis].
    Hamasaki S; Furuya T; Motomura M; Shirabe S; Nakamura T
    Rinsho Shinkeigaku; 1998 Jul; 38(7):697-9. PubMed ID: 9868321
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aberrant Hyperconnectivity in the Motor System at Rest Is Linked to Motor Abnormalities in Schizophrenia Spectrum Disorders.
    Walther S; Stegmayer K; Federspiel A; Bohlhalter S; Wiest R; Viher PV
    Schizophr Bull; 2017 Sep; 43(5):982-992. PubMed ID: 28911049
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Paroxysmal dyskinesias as the initial manifestation of multiple sclerosis].
    Masjuán J; Buisán J; Gimeno A; Alvarez-Cermeño JC
    Neurologia; 1998 Jan; 13(1):45-8. PubMed ID: 9580272
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Levetiracetam for the treatment of generalized dystonia.
    Sullivan KL; Hauser RA; Louis ED; Chari G; Zesiewicz TA
    Parkinsonism Relat Disord; 2005 Nov; 11(7):469-71. PubMed ID: 16014339
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lack of efficacy of levetiracetam in oromandibular and cranial dystonia.
    Park JE; Srivanitchapoom P; Maurer CW; Mathew P; Sackett J; Paine R; Ramos VL; Hallett M
    Acta Neurol Scand; 2017 Aug; 136(2):103-108. PubMed ID: 27808417
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prehospital treatment with levetiracetam plus clonazepam or placebo plus clonazepam in status epilepticus (SAMUKeppra): a randomised, double-blind, phase 3 trial.
    Navarro V; Dagron C; Elie C; Lamhaut L; Demeret S; Urien S; An K; Bolgert F; Tréluyer JM; Baulac M; Carli P;
    Lancet Neurol; 2016 Jan; 15(1):47-55. PubMed ID: 26627366
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Carbamazepine for paroxysmal dystonia due to spinal cord lesions.
    Previdi P; Buzzi P
    Ital J Neurol Sci; 1993 May; 14(4):337. PubMed ID: 8325773
    [No Abstract]   [Full Text] [Related]  

  • 31. Botulinum toxin A improves involuntary limb movements in Rasmussen syndrome.
    Lozsadi DA; Hart IK; Moore AP
    Neurology; 2004 Apr; 62(7):1233-4. PubMed ID: 15079040
    [No Abstract]   [Full Text] [Related]  

  • 32. Intravenous levetiracetam for treatment of neonatal seizures.
    Rakshasbhuvankar A; Rao S; Kohan R; Simmer K; Nagarajan L
    J Clin Neurosci; 2013 Aug; 20(8):1165-7. PubMed ID: 23664133
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of the antiepileptic therapy on olfactory disorders associated with mesial temporal sclerosis.
    Caminiti F; De Salvo S; Nunnari D; Bramanti P; Ciurleo R; Granata F; Marino S
    Neurocase; 2016 Aug; 22(4):357-61. PubMed ID: 27347726
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dystonia associated with pontomesencephalic lesions.
    Loher TJ; Krauss JK
    Mov Disord; 2009 Jan; 24(2):157-67. PubMed ID: 18951533
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Levetiracetam has no significant gamma-aminobutyric acid-related effect on paired-pulse interaction in the dentate gyrus of rats.
    Margineanu DG; Klitgaard H
    Eur J Pharmacol; 2003 Apr; 466(3):255-61. PubMed ID: 12694808
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Continuation rates of levetiracetam in children from the EULEVp cohort study.
    Dureau-Pournin C; Pédespan JM; Droz-Perroteau C; Lavernhe G; Mann M; Pollet C; Robinson P; Jové J; Moore N; Fourrier-Réglat A;
    Eur J Paediatr Neurol; 2014 Jan; 18(1):19-24. PubMed ID: 24035600
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An open trial of levetiracetam for segmental and generalized dystonia.
    Hering S; Wenning GK; Seppi K; Poewe W; Mueller J
    Mov Disord; 2007 Aug; 22(11):1649-51. PubMed ID: 17557353
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical, cognitive, and neurophysiologic correlates of short-term treatment with carbamazepine, oxcarbazepine, and levetiracetam in healthy volunteers.
    Mecarelli O; Vicenzini E; Pulitano P; Vanacore N; Romolo FS; Di Piero V; Lenzi GL; Accornero N
    Ann Pharmacother; 2004 Nov; 38(11):1816-22. PubMed ID: 15367726
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Post-stroke movement disorders: report of 56 patients.
    Alarcón F; Zijlmans JC; Dueñas G; Cevallos N
    J Neurol Neurosurg Psychiatry; 2004 Nov; 75(11):1568-74. PubMed ID: 15489389
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of acetazolamide for long-lasting paroxysmal dystonia in a patient with multiple sclerosis: a case report and review of literature.
    Hsieh PC; Chen SM; Guo YH; Kuan TS; Yen WJ; Chang WC; Lin YC
    Neuropsychiatr Dis Treat; 2013; 9():445-8. PubMed ID: 23589690
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.